| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parathyroid Hormone | 113 | 2022 | 1797 | 7.000 |
Why?
|
| Parathyroid Hormone-Related Protein | 56 | 2022 | 327 | 4.890 |
Why?
|
| Osteoblasts | 60 | 2021 | 1142 | 4.870 |
Why?
|
| Bone Development | 32 | 2021 | 472 | 4.740 |
Why?
|
| Chondrocytes | 41 | 2021 | 791 | 4.640 |
Why?
|
| Bone and Bones | 49 | 2018 | 2560 | 3.980 |
Why?
|
| Growth Plate | 25 | 2021 | 274 | 3.630 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 49 | 2022 | 305 | 3.550 |
Why?
|
| Osteogenesis | 31 | 2021 | 1271 | 2.740 |
Why?
|
| Receptors, Parathyroid Hormone | 44 | 2022 | 332 | 2.630 |
Why?
|
| Osteocytes | 12 | 2021 | 192 | 2.570 |
Why?
|
| Mesenchymal Stem Cells | 14 | 2018 | 1634 | 1.510 |
Why?
|
| Cell Lineage | 18 | 2019 | 2533 | 1.440 |
Why?
|
| Cell Differentiation | 48 | 2021 | 11481 | 1.400 |
Why?
|
| Histone Deacetylases | 7 | 2020 | 718 | 1.300 |
Why?
|
| Hypertrophy | 8 | 2020 | 555 | 1.280 |
Why?
|
| Stem Cells | 16 | 2023 | 3523 | 1.270 |
Why?
|
| Signal Transduction | 56 | 2022 | 23376 | 1.240 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 9 | 2015 | 195 | 1.170 |
Why?
|
| Proteins | 36 | 2004 | 6029 | 1.150 |
Why?
|
| Trans-Activators | 17 | 2020 | 2860 | 1.070 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 9 | 2019 | 158 | 1.050 |
Why?
|
| Cartilage | 14 | 2021 | 806 | 0.990 |
Why?
|
| Mice | 137 | 2023 | 81208 | 0.960 |
Why?
|
| Bone Marrow Cells | 26 | 2017 | 2414 | 0.920 |
Why?
|
| GTP-Binding Protein alpha Subunits | 3 | 2014 | 102 | 0.920 |
Why?
|
| Animals | 217 | 2023 | 167963 | 0.890 |
Why?
|
| Protein Precursors | 28 | 2009 | 1134 | 0.860 |
Why?
|
| Hemoglobins, Abnormal | 22 | 1991 | 119 | 0.840 |
Why?
|
| Mice, Transgenic | 40 | 2022 | 9530 | 0.840 |
Why?
|
| Mice, Knockout | 52 | 2020 | 14372 | 0.820 |
Why?
|
| Bone Remodeling | 6 | 2019 | 580 | 0.810 |
Why?
|
| Adipogenesis | 4 | 2021 | 358 | 0.780 |
Why?
|
| Bone Regeneration | 3 | 2016 | 432 | 0.750 |
Why?
|
| Mesoderm | 3 | 2021 | 672 | 0.730 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 13 | 2017 | 1652 | 0.730 |
Why?
|
| Gene Expression Regulation, Developmental | 19 | 2021 | 3604 | 0.710 |
Why?
|
| Wnt Proteins | 8 | 2015 | 719 | 0.680 |
Why?
|
| Thalassemia | 21 | 1991 | 270 | 0.670 |
Why?
|
| Glycoproteins | 9 | 2017 | 2208 | 0.650 |
Why?
|
| Genes | 26 | 1994 | 1845 | 0.630 |
Why?
|
| Type C Phospholipases | 5 | 2010 | 287 | 0.620 |
Why?
|
| Chondrogenesis | 6 | 2009 | 239 | 0.590 |
Why?
|
| Hedgehog Proteins | 19 | 2014 | 769 | 0.580 |
Why?
|
| Hematopoietic Stem Cells | 13 | 2011 | 3387 | 0.580 |
Why?
|
| Osteoporosis | 10 | 2022 | 1600 | 0.570 |
Why?
|
| Transcription Factors | 19 | 2021 | 12103 | 0.540 |
Why?
|
| Calcium | 14 | 2015 | 5725 | 0.520 |
Why?
|
| Protein Sorting Signals | 9 | 1995 | 279 | 0.520 |
Why?
|
| Osteoclasts | 11 | 2018 | 711 | 0.520 |
Why?
|
| In Situ Hybridization | 17 | 2018 | 1900 | 0.510 |
Why?
|
| Tooth Root | 1 | 2016 | 162 | 0.500 |
Why?
|
| Colony-Forming Units Assay | 11 | 2019 | 351 | 0.500 |
Why?
|
| Cell Proliferation | 16 | 2020 | 10446 | 0.490 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2018 | 600 | 0.490 |
Why?
|
| Organogenesis | 1 | 2016 | 215 | 0.480 |
Why?
|
| Fetal Blood | 8 | 2015 | 1343 | 0.470 |
Why?
|
| Minerals | 1 | 2016 | 283 | 0.470 |
Why?
|
| Globins | 10 | 1991 | 403 | 0.460 |
Why?
|
| Bone Resorption | 7 | 2021 | 720 | 0.450 |
Why?
|
| Osteocalcin | 9 | 2015 | 274 | 0.450 |
Why?
|
| Protein Kinases | 4 | 2018 | 1612 | 0.440 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2014 | 143 | 0.440 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 4 | 2010 | 97 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 31 | 2022 | 22023 | 0.430 |
Why?
|
| Teriparatide | 5 | 2017 | 227 | 0.410 |
Why?
|
| Bone Marrow | 18 | 2014 | 2912 | 0.400 |
Why?
|
| Cyclic AMP | 19 | 2014 | 1456 | 0.400 |
Why?
|
| Calcitriol | 8 | 1998 | 297 | 0.390 |
Why?
|
| RNA, Messenger | 38 | 2019 | 12766 | 0.390 |
Why?
|
| Neutropenia | 7 | 1994 | 884 | 0.380 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2018 | 5643 | 0.370 |
Why?
|
| Embryonic Induction | 6 | 2002 | 151 | 0.370 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1245 | 0.370 |
Why?
|
| Embryo, Mammalian | 8 | 2015 | 1674 | 0.360 |
Why?
|
| Receptors, Cell Surface | 13 | 2008 | 2825 | 0.360 |
Why?
|
| DNA | 32 | 2005 | 7233 | 0.350 |
Why?
|
| GTP-Binding Proteins | 3 | 2014 | 951 | 0.350 |
Why?
|
| Immunoglobulin Light Chains | 6 | 1989 | 286 | 0.340 |
Why?
|
| Stromal Cells | 7 | 2018 | 1326 | 0.340 |
Why?
|
| Adipocytes | 5 | 2018 | 1179 | 0.340 |
Why?
|
| Nuclear Proteins | 5 | 2009 | 5791 | 0.320 |
Why?
|
| Maternal-Fetal Exchange | 4 | 2001 | 463 | 0.320 |
Why?
|
| Parathyroid Glands | 12 | 2004 | 517 | 0.320 |
Why?
|
| Rats | 43 | 2022 | 23711 | 0.320 |
Why?
|
| Transcription, Genetic | 25 | 2020 | 7593 | 0.310 |
Why?
|
| Gene Expression Regulation | 21 | 2021 | 11903 | 0.310 |
Why?
|
| Lactoglobulins | 5 | 1986 | 22 | 0.310 |
Why?
|
| Proto-Oncogene Proteins A-raf | 1 | 2007 | 9 | 0.300 |
Why?
|
| Lymphopoiesis | 1 | 2008 | 133 | 0.300 |
Why?
|
| Tooth Eruption | 2 | 2018 | 29 | 0.300 |
Why?
|
| Hypophosphatemia | 2 | 2013 | 93 | 0.300 |
Why?
|
| Molecular Sequence Data | 43 | 2014 | 17624 | 0.300 |
Why?
|
| Homeostasis | 4 | 2015 | 3306 | 0.300 |
Why?
|
| Base Sequence | 41 | 2008 | 12446 | 0.300 |
Why?
|
| Purpura, Thrombocytopenic | 5 | 1997 | 41 | 0.300 |
Why?
|
| Skull | 3 | 2018 | 815 | 0.290 |
Why?
|
| Green Fluorescent Proteins | 5 | 2017 | 2057 | 0.290 |
Why?
|
| Cells, Cultured | 31 | 2020 | 18957 | 0.290 |
Why?
|
| Chromosome Mapping | 16 | 1989 | 4625 | 0.290 |
Why?
|
| Amino Acid Sequence | 42 | 2022 | 13451 | 0.290 |
Why?
|
| Stem Cell Niche | 2 | 2018 | 346 | 0.290 |
Why?
|
| Lactoferrin | 5 | 1986 | 100 | 0.290 |
Why?
|
| Placenta | 5 | 2003 | 1702 | 0.290 |
Why?
|
| Blood Donors | 3 | 1999 | 343 | 0.280 |
Why?
|
| Humans | 261 | 2023 | 760621 | 0.280 |
Why?
|
| Gene Deletion | 12 | 2019 | 2668 | 0.280 |
Why?
|
| Receptors, Steroid | 3 | 1992 | 154 | 0.280 |
Why?
|
| Cloning, Molecular | 18 | 1996 | 4169 | 0.270 |
Why?
|
| Homeodomain Proteins | 4 | 2018 | 2414 | 0.260 |
Why?
|
| Ribonuclease III | 1 | 2008 | 279 | 0.260 |
Why?
|
| Fever | 5 | 1994 | 1617 | 0.260 |
Why?
|
| Immunoglobulin Isotypes | 5 | 1989 | 158 | 0.250 |
Why?
|
| Cell Division | 15 | 2004 | 4463 | 0.250 |
Why?
|
| Multiple Myeloma | 11 | 2016 | 5130 | 0.250 |
Why?
|
| Bone Diseases | 2 | 2021 | 419 | 0.250 |
Why?
|
| Factor VIII | 5 | 1987 | 349 | 0.250 |
Why?
|
| Phenotype | 26 | 2019 | 16546 | 0.250 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 616 | 0.240 |
Why?
|
| Blood Vessels | 1 | 2010 | 1112 | 0.240 |
Why?
|
| Embryonic and Fetal Development | 5 | 2001 | 420 | 0.240 |
Why?
|
| RANK Ligand | 5 | 2016 | 318 | 0.240 |
Why?
|
| Blood Transfusion | 7 | 1999 | 1328 | 0.230 |
Why?
|
| Cartilage, Articular | 4 | 2023 | 1091 | 0.230 |
Why?
|
| Periosteum | 2 | 2017 | 138 | 0.230 |
Why?
|
| Peptide Fragments | 16 | 2005 | 5125 | 0.230 |
Why?
|
| DNA Restriction Enzymes | 17 | 1988 | 553 | 0.220 |
Why?
|
| Pulmonary Surfactants | 1 | 2004 | 161 | 0.220 |
Why?
|
| Cell Line | 32 | 2020 | 15620 | 0.220 |
Why?
|
| Endothelial Cells | 2 | 2014 | 3539 | 0.220 |
Why?
|
| Parathyroid Neoplasms | 8 | 1993 | 241 | 0.220 |
Why?
|
| Bone Morphogenetic Proteins | 5 | 2010 | 841 | 0.220 |
Why?
|
| Adaptor Proteins, Signal Transducing | 9 | 2017 | 2895 | 0.220 |
Why?
|
| B-Lymphocytes | 5 | 2009 | 4742 | 0.220 |
Why?
|
| beta Catenin | 4 | 2021 | 1043 | 0.220 |
Why?
|
| Fetus | 4 | 2001 | 1859 | 0.210 |
Why?
|
| Collagen Type I | 5 | 2020 | 616 | 0.200 |
Why?
|
| Bromodeoxyuridine | 3 | 2012 | 311 | 0.200 |
Why?
|
| Collagen Type II | 4 | 2023 | 148 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 11 | 2014 | 5785 | 0.200 |
Why?
|
| Neoplasm Proteins | 4 | 2016 | 3610 | 0.200 |
Why?
|
| Phosphorylation | 7 | 2020 | 8313 | 0.200 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 1996 | 788 | 0.200 |
Why?
|
| Disease Models, Animal | 6 | 2023 | 18137 | 0.200 |
Why?
|
| Bone Density Conservation Agents | 2 | 2022 | 796 | 0.200 |
Why?
|
| Hematopoiesis | 9 | 2014 | 2050 | 0.190 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 653 | 0.190 |
Why?
|
| Australia | 21 | 1999 | 1289 | 0.190 |
Why?
|
| Immunoglobulin kappa-Chains | 5 | 1995 | 169 | 0.190 |
Why?
|
| Antigens, CD | 3 | 2003 | 4000 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2017 | 4573 | 0.190 |
Why?
|
| Bone Marrow Transplantation | 6 | 2009 | 2693 | 0.190 |
Why?
|
| Agranulocytosis | 6 | 1996 | 99 | 0.190 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 114 | 0.180 |
Why?
|
| Phosphates | 2 | 2002 | 772 | 0.180 |
Why?
|
| Thymosin | 2 | 1991 | 47 | 0.180 |
Why?
|
| Protein Biosynthesis | 16 | 2001 | 2105 | 0.180 |
Why?
|
| SOX9 Transcription Factor | 3 | 2017 | 145 | 0.180 |
Why?
|
| Etidronic Acid | 1 | 2000 | 63 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2009 | 3484 | 0.180 |
Why?
|
| Dental Sac | 2 | 2018 | 5 | 0.180 |
Why?
|
| Lactation | 2 | 2005 | 397 | 0.180 |
Why?
|
| Aggrecans | 2 | 2023 | 87 | 0.180 |
Why?
|
| Bacterial Infections | 6 | 1994 | 1403 | 0.180 |
Why?
|
| Pregnancy Complications, Hematologic | 5 | 1997 | 177 | 0.170 |
Why?
|
| Up-Regulation | 6 | 2015 | 4122 | 0.170 |
Why?
|
| Chemokine CXCL12 | 2 | 2014 | 454 | 0.170 |
Why?
|
| Pregnancy | 26 | 2015 | 29749 | 0.170 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 186 | 0.170 |
Why?
|
| Organ Culture Techniques | 4 | 2008 | 796 | 0.170 |
Why?
|
| Symporters | 1 | 2002 | 361 | 0.170 |
Why?
|
| Mast Cells | 6 | 1990 | 1390 | 0.170 |
Why?
|
| Autoantibodies | 6 | 1992 | 2118 | 0.170 |
Why?
|
| Plasmids | 16 | 1995 | 2275 | 0.170 |
Why?
|
| Granulocytes | 7 | 1986 | 551 | 0.170 |
Why?
|
| Polycythemia | 3 | 1985 | 125 | 0.160 |
Why?
|
| Immunoglobulin lambda-Chains | 4 | 1989 | 82 | 0.160 |
Why?
|
| Fibrinogen | 4 | 1985 | 886 | 0.160 |
Why?
|
| Dendrites | 1 | 2021 | 475 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 2640 | 0.160 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2016 | 435 | 0.160 |
Why?
|
| Models, Biological | 6 | 2018 | 9467 | 0.160 |
Why?
|
| Leukemia, Myeloid | 7 | 1991 | 695 | 0.160 |
Why?
|
| Microsomes | 4 | 1992 | 252 | 0.160 |
Why?
|
| Female | 118 | 2022 | 391270 | 0.160 |
Why?
|
| Fibroblast Growth Factors | 3 | 2016 | 869 | 0.160 |
Why?
|
| Leukemia, Hairy Cell | 2 | 1988 | 82 | 0.160 |
Why?
|
| Radioimmunoassay | 8 | 1992 | 866 | 0.160 |
Why?
|
| Antibodies | 4 | 2017 | 2421 | 0.160 |
Why?
|
| Neural Crest | 1 | 2021 | 279 | 0.160 |
Why?
|
| Lymphoma | 5 | 1995 | 1898 | 0.150 |
Why?
|
| Hematologic Diseases | 3 | 1994 | 496 | 0.150 |
Why?
|
| Rho(D) Immune Globulin | 1 | 1998 | 34 | 0.150 |
Why?
|
| Anabolic Agents | 3 | 2015 | 253 | 0.150 |
Why?
|
| Restriction Mapping | 9 | 2001 | 852 | 0.150 |
Why?
|
| Splenectomy | 5 | 2001 | 391 | 0.150 |
Why?
|
| Neuropeptides | 1 | 2004 | 943 | 0.150 |
Why?
|
| Autocrine Communication | 1 | 2018 | 169 | 0.150 |
Why?
|
| Osteoporotic Fractures | 1 | 2022 | 409 | 0.150 |
Why?
|
| Point Mutation | 4 | 1997 | 1594 | 0.150 |
Why?
|
| Osteopontin | 2 | 2011 | 302 | 0.150 |
Why?
|
| Immunohistochemistry | 11 | 2014 | 11071 | 0.150 |
Why?
|
| Thrombin | 4 | 1992 | 593 | 0.150 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2007 | 2053 | 0.150 |
Why?
|
| Etoposide | 4 | 1993 | 630 | 0.150 |
Why?
|
| Primary Myelofibrosis | 3 | 2011 | 210 | 0.140 |
Why?
|
| Lupus Coagulation Inhibitor | 4 | 1992 | 33 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 5 | 1995 | 1974 | 0.140 |
Why?
|
| Ribs | 1 | 2019 | 252 | 0.140 |
Why?
|
| Mutation | 25 | 2021 | 29932 | 0.140 |
Why?
|
| Proteoglycans | 2 | 2023 | 801 | 0.140 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2000 | 393 | 0.140 |
Why?
|
| DNA Primers | 4 | 2008 | 2819 | 0.140 |
Why?
|
| Tobramycin | 2 | 1994 | 67 | 0.140 |
Why?
|
| Membrane Glycoproteins | 4 | 2003 | 3707 | 0.140 |
Why?
|
| ABO Blood-Group System | 2 | 1989 | 369 | 0.140 |
Why?
|
| Lymphocytes | 4 | 1988 | 2611 | 0.140 |
Why?
|
| Animals, Newborn | 4 | 2019 | 2672 | 0.130 |
Why?
|
| Dental Cementum | 1 | 2016 | 53 | 0.130 |
Why?
|
| Multiple Trauma | 1 | 1999 | 369 | 0.130 |
Why?
|
| Hemophilia A | 5 | 1984 | 359 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2021 | 1152 | 0.130 |
Why?
|
| beta-Galactosidase | 2 | 2012 | 575 | 0.130 |
Why?
|
| Male | 98 | 2021 | 359744 | 0.130 |
Why?
|
| Gene Expression | 10 | 2014 | 7588 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 686 | 0.130 |
Why?
|
| Diphosphonates | 1 | 2000 | 638 | 0.130 |
Why?
|
| 3T3 Cells | 4 | 2014 | 1085 | 0.130 |
Why?
|
| Fractures, Bone | 2 | 2022 | 2041 | 0.120 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2020 | 530 | 0.120 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 1885 | 0.120 |
Why?
|
| Hypoparathyroidism | 3 | 1995 | 136 | 0.120 |
Why?
|
| Collagen Type X | 2 | 2004 | 16 | 0.120 |
Why?
|
| Colony-Stimulating Factors | 4 | 1986 | 218 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 5 | 2001 | 6068 | 0.120 |
Why?
|
| Interferon Type I | 2 | 1988 | 559 | 0.120 |
Why?
|
| Heterozygote | 8 | 2005 | 2798 | 0.120 |
Why?
|
| Models, Animal | 2 | 2014 | 2117 | 0.120 |
Why?
|
| Down-Regulation | 4 | 2008 | 2913 | 0.120 |
Why?
|
| Leukemia, Monocytic, Acute | 2 | 1993 | 58 | 0.120 |
Why?
|
| Hominidae | 1 | 1994 | 68 | 0.120 |
Why?
|
| Transfection | 13 | 2001 | 5781 | 0.120 |
Why?
|
| Ceftazidime | 2 | 1994 | 57 | 0.110 |
Why?
|
| Tibia | 4 | 2012 | 1065 | 0.110 |
Why?
|
| Metatarsal Bones | 2 | 2006 | 111 | 0.110 |
Why?
|
| Abdominal Neoplasms | 1 | 1995 | 286 | 0.110 |
Why?
|
| Epistasis, Genetic | 1 | 2016 | 350 | 0.110 |
Why?
|
| Gastroenterology | 1 | 2000 | 571 | 0.110 |
Why?
|
| Microscopy, Electron | 5 | 2004 | 2558 | 0.110 |
Why?
|
| Orthopedics | 1 | 2022 | 892 | 0.110 |
Why?
|
| Polycythemia Vera | 4 | 1984 | 160 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2020 | 1485 | 0.110 |
Why?
|
| Cyclins | 6 | 1993 | 593 | 0.110 |
Why?
|
| Osteosarcoma | 7 | 1993 | 897 | 0.110 |
Why?
|
| Mandible | 1 | 2018 | 750 | 0.110 |
Why?
|
| Genes, Reporter | 1 | 2017 | 1529 | 0.110 |
Why?
|
| Feedback | 5 | 2001 | 791 | 0.110 |
Why?
|
| Germinoma | 1 | 1993 | 132 | 0.110 |
Why?
|
| Hemoglobinopathies | 2 | 1991 | 96 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 5 | 2014 | 483 | 0.110 |
Why?
|
| Expert Systems | 1 | 1993 | 79 | 0.110 |
Why?
|
| Introns | 2 | 1996 | 978 | 0.110 |
Why?
|
| Adenoma | 7 | 1993 | 2148 | 0.110 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2015 | 161 | 0.100 |
Why?
|
| Pedigree | 14 | 2001 | 4578 | 0.100 |
Why?
|
| Chick Embryo | 4 | 2009 | 981 | 0.100 |
Why?
|
| Thrombophlebitis | 2 | 1992 | 288 | 0.100 |
Why?
|
| Ceftriaxone | 1 | 1993 | 176 | 0.100 |
Why?
|
| Prenatal Diagnosis | 5 | 1997 | 1264 | 0.100 |
Why?
|
| Erythrocytes | 6 | 1990 | 2415 | 0.100 |
Why?
|
| Reticulocytes | 4 | 1995 | 288 | 0.100 |
Why?
|
| T-Lymphocytes | 6 | 2015 | 10181 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2007 | 621 | 0.100 |
Why?
|
| Myelopoiesis | 1 | 2012 | 134 | 0.100 |
Why?
|
| Apoptosis | 5 | 2017 | 9501 | 0.100 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 2 | 1989 | 317 | 0.100 |
Why?
|
| Postpartum Period | 2 | 1997 | 1167 | 0.100 |
Why?
|
| Gallium Radioisotopes | 3 | 1989 | 195 | 0.100 |
Why?
|
| Protein Isoforms | 1 | 2016 | 1697 | 0.100 |
Why?
|
| Odontoblasts | 1 | 2011 | 14 | 0.100 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2010 | 613 | 0.100 |
Why?
|
| Adult | 73 | 2023 | 219994 | 0.100 |
Why?
|
| Anemia, Aplastic | 3 | 1986 | 228 | 0.100 |
Why?
|
| Hemoglobin J | 1 | 1991 | 3 | 0.100 |
Why?
|
| Endopeptidases | 2 | 1995 | 772 | 0.100 |
Why?
|
| Ferritins | 2 | 1988 | 597 | 0.090 |
Why?
|
| Amino Acids | 7 | 1997 | 1714 | 0.090 |
Why?
|
| Genes, Regulator | 2 | 1989 | 374 | 0.090 |
Why?
|
| Blood Coagulation Factors | 3 | 1989 | 365 | 0.090 |
Why?
|
| Chimera | 3 | 1998 | 453 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2012 | 213 | 0.090 |
Why?
|
| Hemoglobin H | 4 | 1989 | 13 | 0.090 |
Why?
|
| Intracellular Membranes | 1 | 1992 | 389 | 0.090 |
Why?
|
| Antigens | 3 | 1987 | 1447 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2000 | 2145 | 0.090 |
Why?
|
| Meningitis, Aseptic | 1 | 1991 | 59 | 0.090 |
Why?
|
| Leukemia | 6 | 1988 | 1520 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2018 | 4550 | 0.090 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 791 | 0.090 |
Why?
|
| Cyclosporins | 2 | 1989 | 216 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 7 | 1997 | 1693 | 0.090 |
Why?
|
| Mice, Inbred Strains | 3 | 2003 | 1763 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 2 | 2001 | 4713 | 0.090 |
Why?
|
| Hodgkin Disease | 3 | 1989 | 1378 | 0.090 |
Why?
|
| von Willebrand Diseases | 3 | 1988 | 132 | 0.090 |
Why?
|
| Calcitonin | 4 | 2001 | 330 | 0.090 |
Why?
|
| Caspase 9 | 1 | 2010 | 185 | 0.090 |
Why?
|
| Mammary Glands, Animal | 2 | 2005 | 271 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 3 | 2015 | 1067 | 0.090 |
Why?
|
| Thrombocytopenia | 5 | 2001 | 1174 | 0.090 |
Why?
|
| Receptors, Calcitriol | 4 | 1996 | 359 | 0.090 |
Why?
|
| Azlocillin | 1 | 1989 | 19 | 0.090 |
Why?
|
| Thymus Gland | 1 | 2015 | 1247 | 0.090 |
Why?
|
| Tamoxifen | 1 | 2014 | 963 | 0.090 |
Why?
|
| Ligands | 4 | 2022 | 3276 | 0.090 |
Why?
|
| Amikacin | 1 | 1989 | 48 | 0.090 |
Why?
|
| Folic Acid | 2 | 1990 | 1309 | 0.090 |
Why?
|
| Hormone Replacement Therapy | 1 | 2015 | 755 | 0.090 |
Why?
|
| Phytohemagglutinins | 1 | 1989 | 168 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 1602 | 0.090 |
Why?
|
| Blotting, Western | 5 | 2010 | 5039 | 0.090 |
Why?
|
| Cell Enlargement | 2 | 2008 | 60 | 0.080 |
Why?
|
| Serine Endopeptidases | 1 | 1995 | 1021 | 0.080 |
Why?
|
| Tooth | 1 | 2011 | 208 | 0.080 |
Why?
|
| Blood Group Antigens | 1 | 1991 | 187 | 0.080 |
Why?
|
| Structure-Activity Relationship | 8 | 1997 | 3084 | 0.080 |
Why?
|
| Blood Coagulation | 5 | 1980 | 1157 | 0.080 |
Why?
|
| Clinical Enzyme Tests | 1 | 1989 | 115 | 0.080 |
Why?
|
| Blood Cell Count | 3 | 1987 | 397 | 0.080 |
Why?
|
| Testicular Neoplasms | 2 | 1993 | 801 | 0.080 |
Why?
|
| Hematology | 1 | 1993 | 241 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2014 | 1356 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2014 | 752 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 3442 | 0.080 |
Why?
|
| Genotype | 9 | 2014 | 12960 | 0.080 |
Why?
|
| Cardiolipins | 1 | 1989 | 81 | 0.080 |
Why?
|
| DNA, Recombinant | 6 | 1988 | 455 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 7 | 1990 | 9185 | 0.080 |
Why?
|
| Fracture Healing | 1 | 2012 | 438 | 0.080 |
Why?
|
| Drug Therapy, Combination | 3 | 1994 | 6498 | 0.080 |
Why?
|
| Rheumatology | 1 | 2015 | 611 | 0.080 |
Why?
|
| Catheters, Indwelling | 2 | 1994 | 428 | 0.080 |
Why?
|
| Leukemia, Lymphoid | 3 | 1987 | 310 | 0.080 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 1989 | 63 | 0.080 |
Why?
|
| Antigens, Differentiation | 2 | 1989 | 911 | 0.080 |
Why?
|
| Thymidine Kinase | 1 | 1989 | 286 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 1996 | 1415 | 0.080 |
Why?
|
| Membrane Proteins | 3 | 2015 | 7850 | 0.080 |
Why?
|
| Amyloidosis | 1 | 1995 | 817 | 0.080 |
Why?
|
| Neutrophils | 10 | 1986 | 3767 | 0.080 |
Why?
|
| Immunization, Passive | 1 | 1991 | 616 | 0.080 |
Why?
|
| Oncogenes | 6 | 1993 | 1220 | 0.080 |
Why?
|
| Gene Rearrangement | 3 | 1993 | 1122 | 0.080 |
Why?
|
| Crosses, Genetic | 3 | 2000 | 751 | 0.080 |
Why?
|
| Nucleic Acid Hybridization | 11 | 1993 | 1304 | 0.080 |
Why?
|
| Caspase 3 | 1 | 2010 | 731 | 0.080 |
Why?
|
| Blood Preservation | 2 | 1987 | 168 | 0.080 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2009 | 180 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1994 | 1055 | 0.080 |
Why?
|
| Receptors, Calcium-Sensing | 2 | 2001 | 318 | 0.080 |
Why?
|
| Interleukin-7 | 1 | 2008 | 142 | 0.080 |
Why?
|
| Enzyme Activation | 5 | 2007 | 3602 | 0.080 |
Why?
|
| Blood Physiological Phenomena | 1 | 1988 | 53 | 0.080 |
Why?
|
| Isoantibodies | 2 | 1991 | 661 | 0.080 |
Why?
|
| Microbial Collagenase | 1 | 1988 | 113 | 0.070 |
Why?
|
| Mediastinum | 1 | 1989 | 266 | 0.070 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 1989 | 146 | 0.070 |
Why?
|
| Oncogene Proteins | 4 | 1993 | 719 | 0.070 |
Why?
|
| Pericytes | 1 | 2010 | 293 | 0.070 |
Why?
|
| ADAM Proteins | 1 | 2009 | 240 | 0.070 |
Why?
|
| Homozygote | 4 | 1996 | 1788 | 0.070 |
Why?
|
| DNA Transposable Elements | 1 | 1991 | 756 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 1999 | 1925 | 0.070 |
Why?
|
| Anemia, Hemolytic | 4 | 1988 | 163 | 0.070 |
Why?
|
| DNA-Binding Proteins | 4 | 2004 | 9585 | 0.070 |
Why?
|
| Calcium, Dietary | 1 | 2010 | 531 | 0.070 |
Why?
|
| Leukocyte Count | 7 | 1988 | 1600 | 0.070 |
Why?
|
| beta 2-Microglobulin | 4 | 1989 | 328 | 0.070 |
Why?
|
| Plateletpheresis | 1 | 1987 | 38 | 0.070 |
Why?
|
| Isoelectric Focusing | 2 | 1984 | 160 | 0.070 |
Why?
|
| Solubility | 2 | 2003 | 1088 | 0.070 |
Why?
|
| Sequence Alignment | 4 | 2014 | 2176 | 0.070 |
Why?
|
| Opossums | 4 | 1994 | 104 | 0.070 |
Why?
|
| Blotting, Northern | 8 | 1994 | 1543 | 0.070 |
Why?
|
| Platelet Aggregation | 2 | 1988 | 805 | 0.070 |
Why?
|
| Factor IX | 2 | 1985 | 77 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 11 | 4 | 1992 | 410 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 7 | 1992 | 1744 | 0.070 |
Why?
|
| Yeasts | 1 | 1987 | 279 | 0.070 |
Why?
|
| Reagent Kits, Diagnostic | 2 | 1990 | 238 | 0.070 |
Why?
|
| Paraproteins | 3 | 1995 | 38 | 0.070 |
Why?
|
| Myeloproliferative Disorders | 2 | 1985 | 609 | 0.070 |
Why?
|
| Binding, Competitive | 4 | 1992 | 1142 | 0.070 |
Why?
|
| Prekallikrein | 1 | 1985 | 11 | 0.070 |
Why?
|
| Tetracycline Resistance | 1 | 2005 | 22 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1992 | 778 | 0.070 |
Why?
|
| Biological Transport | 3 | 2001 | 2086 | 0.070 |
Why?
|
| Chromosome Deletion | 4 | 1992 | 1387 | 0.060 |
Why?
|
| Blood Component Removal | 1 | 1987 | 132 | 0.060 |
Why?
|
| Integrases | 3 | 2015 | 516 | 0.060 |
Why?
|
| Receptors, Fc | 1 | 1989 | 534 | 0.060 |
Why?
|
| Chorionic Villi | 1 | 1985 | 53 | 0.060 |
Why?
|
| Fibrin | 3 | 1983 | 505 | 0.060 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1985 | 144 | 0.060 |
Why?
|
| Receptors, Notch | 2 | 2008 | 743 | 0.060 |
Why?
|
| Hemoglobin, Sickle | 1 | 1986 | 113 | 0.060 |
Why?
|
| Lymph Nodes | 2 | 1995 | 3486 | 0.060 |
Why?
|
| Carrier Proteins | 4 | 2003 | 4938 | 0.060 |
Why?
|
| Joints | 1 | 2007 | 321 | 0.060 |
Why?
|
| Hyperthyroidism | 1 | 1987 | 291 | 0.060 |
Why?
|
| Acridine Orange | 1 | 1985 | 28 | 0.060 |
Why?
|
| Methods | 5 | 1988 | 1074 | 0.060 |
Why?
|
| Cell Separation | 4 | 2012 | 1720 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 2061 | 0.060 |
Why?
|
| Hemophilia B | 1 | 1985 | 84 | 0.060 |
Why?
|
| Protein Conformation | 5 | 1997 | 3969 | 0.060 |
Why?
|
| Blood Coagulation Disorders | 3 | 1985 | 349 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 1988 | 2159 | 0.060 |
Why?
|
| Escherichia coli | 5 | 1991 | 4219 | 0.060 |
Why?
|
| Hindlimb | 1 | 2007 | 510 | 0.060 |
Why?
|
| Autoimmune Diseases | 3 | 1987 | 2250 | 0.060 |
Why?
|
| Plasma Cells | 1 | 1988 | 591 | 0.060 |
Why?
|
| Blotting, Southern | 5 | 1994 | 777 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1989 | 3804 | 0.060 |
Why?
|
| Protein Binding | 7 | 2009 | 9335 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 9 | 2001 | 6131 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2873 | 0.060 |
Why?
|
| Adult Stem Cells | 1 | 2007 | 221 | 0.060 |
Why?
|
| Moloney murine leukemia virus | 1 | 1984 | 109 | 0.060 |
Why?
|
| Fetal Hemoglobin | 3 | 1986 | 342 | 0.060 |
Why?
|
| Chromatography, Ion Exchange | 4 | 1996 | 297 | 0.060 |
Why?
|
| Cattle | 12 | 1998 | 3847 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2004 | 43 | 0.060 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 1984 | 86 | 0.060 |
Why?
|
| Fibrinogens, Abnormal | 1 | 1984 | 10 | 0.060 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1992 | 1375 | 0.060 |
Why?
|
| Antigens, Human Platelet | 2 | 1997 | 41 | 0.060 |
Why?
|
| Afibrinogenemia | 1 | 1984 | 18 | 0.060 |
Why?
|
| Femur | 2 | 2012 | 1302 | 0.060 |
Why?
|
| Erythrocyte Aging | 3 | 1991 | 53 | 0.060 |
Why?
|
| Plasma Exchange | 2 | 1996 | 158 | 0.060 |
Why?
|
| Anemia, Macrocytic | 2 | 1975 | 54 | 0.060 |
Why?
|
| Isoenzymes | 1 | 1989 | 1690 | 0.060 |
Why?
|
| Proteinuria | 1 | 1987 | 594 | 0.060 |
Why?
|
| Infant, Newborn | 8 | 1997 | 26181 | 0.060 |
Why?
|
| Batroxobin | 1 | 1983 | 3 | 0.060 |
Why?
|
| Kallikreins | 1 | 1985 | 231 | 0.060 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2003 | 66 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2010 | 1513 | 0.060 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 77 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2020 | 3517 | 0.060 |
Why?
|
| Spleen | 5 | 2012 | 2298 | 0.060 |
Why?
|
| Bone Density | 5 | 2018 | 3534 | 0.060 |
Why?
|
| Radionuclide Imaging | 7 | 1989 | 1975 | 0.060 |
Why?
|
| Nipples | 1 | 2005 | 221 | 0.060 |
Why?
|
| Cytarabine | 4 | 1994 | 696 | 0.050 |
Why?
|
| Pituitary Neoplasms | 3 | 1988 | 1313 | 0.050 |
Why?
|
| Ulna | 1 | 2004 | 134 | 0.050 |
Why?
|
| Biological Assay | 2 | 1985 | 630 | 0.050 |
Why?
|
| Femur Head Necrosis | 1 | 1984 | 132 | 0.050 |
Why?
|
| Erythropoietin | 3 | 1984 | 720 | 0.050 |
Why?
|
| Organ Size | 2 | 2008 | 2254 | 0.050 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins | 1 | 2002 | 7 | 0.050 |
Why?
|
| Bone Diseases, Metabolic | 3 | 2014 | 409 | 0.050 |
Why?
|
| Biopsy | 4 | 1988 | 6771 | 0.050 |
Why?
|
| Pneumococcal Infections | 1 | 1988 | 503 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2013 | 1933 | 0.050 |
Why?
|
| Antigens, Neoplasm | 2 | 1989 | 1998 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 1983 | 174 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 3844 | 0.050 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2003 | 125 | 0.050 |
Why?
|
| Blood Protein Electrophoresis | 7 | 1986 | 71 | 0.050 |
Why?
|
| Hypercalcemia | 1 | 1985 | 421 | 0.050 |
Why?
|
| Thrombocytosis | 2 | 1999 | 82 | 0.050 |
Why?
|
| Phorbol Esters | 1 | 2002 | 108 | 0.050 |
Why?
|
| Facial Paralysis | 1 | 1987 | 345 | 0.050 |
Why?
|
| Stem Cell Transplantation | 2 | 2012 | 1599 | 0.050 |
Why?
|
| Phosphatidylcholines | 1 | 2004 | 406 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2003 | 1753 | 0.050 |
Why?
|
| Disease | 1 | 1988 | 671 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2002 | 2566 | 0.050 |
Why?
|
| Leukocytes | 4 | 1987 | 2026 | 0.050 |
Why?
|
| Time Factors | 12 | 2009 | 40165 | 0.050 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 9411 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 929 | 0.050 |
Why?
|
| Anemia, Pernicious | 1 | 1982 | 15 | 0.050 |
Why?
|
| Middle Aged | 41 | 2015 | 220352 | 0.050 |
Why?
|
| Precipitin Tests | 3 | 1992 | 814 | 0.050 |
Why?
|
| Receptors, Thrombin | 2 | 1992 | 132 | 0.050 |
Why?
|
| von Willebrand Factor | 4 | 1988 | 673 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12626 | 0.050 |
Why?
|
| Mosaicism | 1 | 2005 | 466 | 0.050 |
Why?
|
| Genetic Linkage | 4 | 2001 | 2381 | 0.050 |
Why?
|
| Culture Techniques | 3 | 1996 | 530 | 0.050 |
Why?
|
| Heparin | 3 | 1987 | 1652 | 0.050 |
Why?
|
| Cell Cycle | 3 | 2008 | 2934 | 0.050 |
Why?
|
| Prothrombin Time | 2 | 1980 | 116 | 0.050 |
Why?
|
| Polyneuropathies | 1 | 1983 | 137 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 1984 | 975 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1984 | 545 | 0.050 |
Why?
|
| Genetics, Population | 1 | 1986 | 930 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 1992 | 2981 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5889 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 4 | 1999 | 2471 | 0.050 |
Why?
|
| Cell Survival | 3 | 2003 | 5797 | 0.050 |
Why?
|
| Recombinant Proteins | 6 | 2008 | 6538 | 0.050 |
Why?
|
| Fibrinolysin | 2 | 1985 | 131 | 0.050 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1982 | 187 | 0.050 |
Why?
|
| Cell Movement | 2 | 2010 | 5206 | 0.050 |
Why?
|
| Erythropoiesis | 2 | 1983 | 682 | 0.050 |
Why?
|
| Iron | 3 | 1988 | 1786 | 0.050 |
Why?
|
| Thromboplastin | 2 | 1980 | 286 | 0.050 |
Why?
|
| Fetal Death | 1 | 2003 | 434 | 0.050 |
Why?
|
| Gene Targeting | 3 | 2005 | 839 | 0.050 |
Why?
|
| beta-Lactamases | 1 | 1983 | 304 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 2802 | 0.050 |
Why?
|
| Adolescent | 22 | 2021 | 87810 | 0.050 |
Why?
|
| Cell Count | 6 | 2003 | 1835 | 0.050 |
Why?
|
| Immunoglobulin G | 3 | 1989 | 4541 | 0.050 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 3 | 2012 | 629 | 0.050 |
Why?
|
| Rabbits | 6 | 1995 | 4773 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 4 | 2003 | 6216 | 0.040 |
Why?
|
| Fetal Development | 1 | 2006 | 766 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 1992 | 1913 | 0.040 |
Why?
|
| High Mobility Group Proteins | 1 | 2001 | 176 | 0.040 |
Why?
|
| Chromosomes, Human, 6-12 and X | 3 | 1985 | 77 | 0.040 |
Why?
|
| X-Ray Microtomography | 2 | 2013 | 443 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 1985 | 911 | 0.040 |
Why?
|
| Collagen Type III | 1 | 2020 | 91 | 0.040 |
Why?
|
| Anemia, Sickle Cell | 2 | 1986 | 1056 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 1993 | 3340 | 0.040 |
Why?
|
| Pregnancy Trimesters | 1 | 2001 | 197 | 0.040 |
Why?
|
| Bone Neoplasms | 3 | 1992 | 2532 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2004 | 716 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 1993 | 11712 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 1988 | 2203 | 0.040 |
Why?
|
| Alendronate | 1 | 2000 | 173 | 0.040 |
Why?
|
| Diagnosis, Differential | 9 | 1995 | 12965 | 0.040 |
Why?
|
| Cell Membrane | 5 | 1995 | 3682 | 0.040 |
Why?
|
| Gold | 1 | 1983 | 484 | 0.040 |
Why?
|
| Apoferritins | 1 | 1979 | 16 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2016 | 2627 | 0.040 |
Why?
|
| Agar | 3 | 1986 | 55 | 0.040 |
Why?
|
| Osteoprotegerin | 2 | 2010 | 177 | 0.040 |
Why?
|
| Remission Induction | 3 | 1989 | 2392 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 2001 | 2262 | 0.040 |
Why?
|
| Ectoderm | 1 | 1999 | 137 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2015 | 801 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2012 | 941 | 0.040 |
Why?
|
| Trypsin | 5 | 1989 | 496 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 1982 | 522 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 20080 | 0.040 |
Why?
|
| Anemia, Hypochromic | 2 | 1975 | 63 | 0.040 |
Why?
|
| Genetic Markers | 3 | 2010 | 2608 | 0.040 |
Why?
|
| Research Design | 1 | 2014 | 6180 | 0.040 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2001 | 491 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2004 | 1139 | 0.040 |
Why?
|
| Binding Sites | 4 | 1995 | 6048 | 0.040 |
Why?
|
| Kidney Calculi | 1 | 2002 | 468 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 1994 | 3465 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1989 | 1628 | 0.040 |
Why?
|
| Aged | 26 | 1999 | 169152 | 0.040 |
Why?
|
| Oxygen | 6 | 1991 | 4193 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 3446 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 1987 | 2299 | 0.040 |
Why?
|
| Kidney | 5 | 1994 | 7064 | 0.040 |
Why?
|
| Cell Death | 1 | 2003 | 1672 | 0.040 |
Why?
|
| Plasma | 1 | 2001 | 584 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1982 | 601 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2020 | 488 | 0.040 |
Why?
|
| Cell Nucleus | 4 | 2014 | 2907 | 0.040 |
Why?
|
| Receptors, Calcitonin | 1 | 1996 | 34 | 0.040 |
Why?
|
| Leiomyoma | 1 | 1982 | 654 | 0.030 |
Why?
|
| Random Allocation | 1 | 2021 | 2394 | 0.030 |
Why?
|
| Oxyhemoglobins | 2 | 1991 | 212 | 0.030 |
Why?
|
| Polynesia | 2 | 1986 | 14 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 1 | 1981 | 566 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2002 | 933 | 0.030 |
Why?
|
| Molecular Weight | 7 | 1990 | 2186 | 0.030 |
Why?
|
| Alleles | 4 | 1998 | 6898 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1996 | 221 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 4490 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 1992 | 1705 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2022 | 1548 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2001 | 707 | 0.030 |
Why?
|
| Blood Coagulation Tests | 4 | 1984 | 270 | 0.030 |
Why?
|
| Anemia, Megaloblastic | 1 | 1975 | 24 | 0.030 |
Why?
|
| Ribose-Phosphate Pyrophosphokinase | 1 | 1975 | 8 | 0.030 |
Why?
|
| Diphosphoglyceric Acids | 2 | 1991 | 31 | 0.030 |
Why?
|
| Erythrocytes, Abnormal | 2 | 1974 | 121 | 0.030 |
Why?
|
| Neprilysin | 2 | 1989 | 472 | 0.030 |
Why?
|
| Methyltestosterone | 1 | 1975 | 19 | 0.030 |
Why?
|
| Phosphoproteins | 2 | 2002 | 2440 | 0.030 |
Why?
|
| Blastocyst | 1 | 1998 | 433 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2020 | 1666 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 829 | 0.030 |
Why?
|
| RNA, Complementary | 1 | 1995 | 45 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 1999 | 918 | 0.030 |
Why?
|
| Splenomegaly | 3 | 1984 | 189 | 0.030 |
Why?
|
| Gravitation | 1 | 2015 | 82 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1996 | 224 | 0.030 |
Why?
|
| Twins | 1 | 1977 | 339 | 0.030 |
Why?
|
| Malaria | 1 | 1985 | 1226 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 3 | 1992 | 1132 | 0.030 |
Why?
|
| Culture Media | 2 | 1988 | 900 | 0.030 |
Why?
|
| Factor X | 2 | 1990 | 64 | 0.030 |
Why?
|
| IgA Deficiency | 1 | 1994 | 43 | 0.030 |
Why?
|
| Thymoma | 1 | 1996 | 187 | 0.030 |
Why?
|
| Body Height | 1 | 2021 | 1570 | 0.030 |
Why?
|
| Peptides | 4 | 1986 | 4354 | 0.030 |
Why?
|
| Proto-Oncogenes | 2 | 1992 | 320 | 0.030 |
Why?
|
| Hypertension | 1 | 2015 | 8594 | 0.030 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 1995 | 65 | 0.030 |
Why?
|
| Epitopes | 4 | 1994 | 2503 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 1992 | 783 | 0.030 |
Why?
|
| New South Wales | 1 | 1994 | 70 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 1987 | 3025 | 0.030 |
Why?
|
| Glycosylation | 2 | 1995 | 1096 | 0.030 |
Why?
|
| Radiation Effects | 1 | 1974 | 69 | 0.030 |
Why?
|
| Kidney Transplantation | 2 | 1989 | 4215 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1983 | 2197 | 0.030 |
Why?
|
| Dexamethasone | 2 | 1994 | 1927 | 0.030 |
Why?
|
| Furosemide | 1 | 2015 | 170 | 0.030 |
Why?
|
| Thymidine | 4 | 1975 | 299 | 0.030 |
Why?
|
| Histidine | 1 | 1975 | 311 | 0.030 |
Why?
|
| Pituitary Gland | 3 | 1989 | 637 | 0.030 |
Why?
|
| Dogs | 4 | 1993 | 3841 | 0.030 |
Why?
|
| Blood Group Incompatibility | 1 | 1995 | 135 | 0.030 |
Why?
|
| Phosphotransferases | 1 | 1975 | 303 | 0.030 |
Why?
|
| Poly A | 1 | 1994 | 181 | 0.030 |
Why?
|
| Fibrinolysis | 3 | 1985 | 332 | 0.030 |
Why?
|
| Immunoelectrophoresis | 2 | 1985 | 104 | 0.030 |
Why?
|
| Recurrence | 2 | 2022 | 8482 | 0.030 |
Why?
|
| Gestational Age | 1 | 2003 | 3565 | 0.030 |
Why?
|
| Blood Component Transfusion | 1 | 1994 | 141 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1996 | 397 | 0.030 |
Why?
|
| Follow-Up Studies | 6 | 2022 | 39261 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1996 | 274 | 0.030 |
Why?
|
| Acute Disease | 6 | 1991 | 7269 | 0.030 |
Why?
|
| Cell Line, Transformed | 3 | 2001 | 869 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2015 | 419 | 0.030 |
Why?
|
| Diaphragm | 2 | 1986 | 351 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1994 | 418 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2013 | 14 | 0.030 |
Why?
|
| Neoplasm Staging | 3 | 1986 | 11152 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 2 | 1987 | 1628 | 0.030 |
Why?
|
| Chemistry | 2 | 1983 | 348 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 1984 | 3075 | 0.030 |
Why?
|
| Thrombosis | 2 | 1987 | 3052 | 0.030 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1994 | 356 | 0.030 |
Why?
|
| Chromogranins | 1 | 2014 | 161 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2013 | 44 | 0.030 |
Why?
|
| Chemical Phenomena | 2 | 1983 | 508 | 0.030 |
Why?
|
| Clone Cells | 5 | 1983 | 1660 | 0.030 |
Why?
|
| Iodine Radioisotopes | 2 | 1990 | 1032 | 0.030 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 1985 | 418 | 0.030 |
Why?
|
| Liver Transplantation | 2 | 1995 | 2325 | 0.030 |
Why?
|
| Exons | 2 | 2001 | 2388 | 0.030 |
Why?
|
| Hemolysis | 1 | 1995 | 423 | 0.030 |
Why?
|
| Uterine Neoplasms | 1 | 1982 | 1439 | 0.030 |
Why?
|
| COS Cells | 3 | 2001 | 1129 | 0.030 |
Why?
|
| Fibrosis | 1 | 2020 | 2042 | 0.030 |
Why?
|
| Myocardium | 2 | 2003 | 4700 | 0.030 |
Why?
|
| Serum Albumin | 1 | 1996 | 674 | 0.030 |
Why?
|
| Osteochondrodysplasias | 1 | 1994 | 182 | 0.030 |
Why?
|
| Antigens, Surface | 2 | 1987 | 1608 | 0.030 |
Why?
|
| Cycloheximide | 2 | 1994 | 343 | 0.030 |
Why?
|
| United States | 3 | 2015 | 72461 | 0.030 |
Why?
|
| DNA Probes | 2 | 1993 | 551 | 0.030 |
Why?
|
| Italy | 2 | 1986 | 841 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 5 | 1996 | 3735 | 0.030 |
Why?
|
| Antifibrinolytic Agents | 1 | 1975 | 292 | 0.030 |
Why?
|
| Data Display | 1 | 1993 | 174 | 0.030 |
Why?
|
| Chronic Disease | 5 | 1988 | 9287 | 0.030 |
Why?
|
| Genetic Vectors | 4 | 2001 | 3380 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 1997 | 1871 | 0.030 |
Why?
|
| Aorta | 1 | 2020 | 2039 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2014 | 0.020 |
Why?
|
| Diet | 1 | 2010 | 8010 | 0.020 |
Why?
|
| Erythrocyte Count | 4 | 1985 | 157 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2012 | 234 | 0.020 |
Why?
|
| Infusions, Intravenous | 2 | 2013 | 2234 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 1996 | 579 | 0.020 |
Why?
|
| Eosinophils | 3 | 1987 | 944 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2008 | 3790 | 0.020 |
Why?
|
| Kinetics | 6 | 1994 | 6377 | 0.020 |
Why?
|
| Phospholipids | 1 | 1975 | 789 | 0.020 |
Why?
|
| Prognosis | 8 | 1989 | 29658 | 0.020 |
Why?
|
| New Guinea | 1 | 1991 | 10 | 0.020 |
Why?
|
| Chromium Radioisotopes | 1 | 1991 | 34 | 0.020 |
Why?
|
| Isoelectric Point | 2 | 1983 | 76 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 1837 | 0.020 |
Why?
|
| Drug Design | 1 | 1997 | 1061 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2020 | 8158 | 0.020 |
Why?
|
| Protein Kinase C | 2 | 1994 | 1199 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 1526 | 0.020 |
Why?
|
| 2,3-Diphosphoglycerate | 1 | 1991 | 13 | 0.020 |
Why?
|
| Collagen | 3 | 2008 | 2636 | 0.020 |
Why?
|
| Blood Banks | 1 | 1992 | 108 | 0.020 |
Why?
|
| Polyribosomes | 3 | 1981 | 109 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 1994 | 979 | 0.020 |
Why?
|
| Inpatients | 1 | 2022 | 2581 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 1997 | 1296 | 0.020 |
Why?
|
| Heart | 2 | 2003 | 4393 | 0.020 |
Why?
|
| Hyperparathyroidism | 1 | 1992 | 339 | 0.020 |
Why?
|
| Anticoagulants | 4 | 1985 | 4897 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1992 | 373 | 0.020 |
Why?
|
| Postoperative Period | 2 | 1988 | 1818 | 0.020 |
Why?
|
| Dithiothreitol | 1 | 1990 | 95 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 2418 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 1994 | 1991 | 0.020 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1980 | 1419 | 0.020 |
Why?
|
| Incisor | 1 | 2011 | 174 | 0.020 |
Why?
|
| Floxacillin | 1 | 1989 | 3 | 0.020 |
Why?
|
| Hemoglobinometry | 3 | 1984 | 35 | 0.020 |
Why?
|
| Morphogenesis | 3 | 2000 | 740 | 0.020 |
Why?
|
| Sarcoma, Experimental | 1 | 1990 | 117 | 0.020 |
Why?
|
| Genes, Lethal | 2 | 2004 | 225 | 0.020 |
Why?
|
| Drug Evaluation | 2 | 1988 | 641 | 0.020 |
Why?
|
| Cyclin D1 | 4 | 1993 | 451 | 0.020 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1991 | 303 | 0.020 |
Why?
|
| Hot Temperature | 4 | 1998 | 1435 | 0.020 |
Why?
|
| Phenothiazines | 1 | 1969 | 61 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 1983 | 3826 | 0.020 |
Why?
|
| Therapeutic Equivalency | 1 | 1989 | 136 | 0.020 |
Why?
|
| Tritium | 3 | 1974 | 707 | 0.020 |
Why?
|
| Pokeweed Mitogens | 1 | 1989 | 38 | 0.020 |
Why?
|
| Macrophages | 2 | 1986 | 5745 | 0.020 |
Why?
|
| Hemoglobinuria, Paroxysmal | 3 | 1979 | 95 | 0.020 |
Why?
|
| Partial Thromboplastin Time | 2 | 1988 | 205 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 16939 | 0.020 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 1988 | 38 | 0.020 |
Why?
|
| DNA, Neoplasm | 3 | 1991 | 1745 | 0.020 |
Why?
|
| Metallothionein | 1 | 1989 | 61 | 0.020 |
Why?
|
| Genes, ras | 1 | 1991 | 655 | 0.020 |
Why?
|
| Morbidity | 1 | 1994 | 1765 | 0.020 |
Why?
|
| Kaolin | 2 | 1978 | 16 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2015 | 1575 | 0.020 |
Why?
|
| Phosphatidylethanolamines | 1 | 1989 | 129 | 0.020 |
Why?
|
| Prednisone | 3 | 1985 | 1565 | 0.020 |
Why?
|
| Hematocrit | 1 | 1990 | 629 | 0.020 |
Why?
|
| Fucosyltransferases | 1 | 1989 | 117 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1984 | 2502 | 0.020 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1988 | 69 | 0.020 |
Why?
|
| Ristocetin | 1 | 1988 | 26 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 458 | 0.020 |
Why?
|
| Isoantigens | 1 | 1990 | 552 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2009 | 290 | 0.020 |
Why?
|
| Forelimb | 1 | 2008 | 115 | 0.020 |
Why?
|
| Polymorphism, Genetic | 4 | 1986 | 4291 | 0.020 |
Why?
|
| Blood Platelets | 3 | 1990 | 2520 | 0.020 |
Why?
|
| Ilium | 1 | 1988 | 154 | 0.020 |
Why?
|
| Graft Survival | 2 | 1989 | 3794 | 0.020 |
Why?
|
| Sodium Chloride | 2 | 1983 | 591 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2001 | 4407 | 0.020 |
Why?
|
| Receptors, IgE | 1 | 1989 | 372 | 0.020 |
Why?
|
| Receptors, Thyrotropin | 1 | 1987 | 45 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2012 | 820 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 1991 | 916 | 0.020 |
Why?
|
| Gangrene | 1 | 1988 | 91 | 0.020 |
Why?
|
| Hyperplasia | 2 | 1988 | 1155 | 0.020 |
Why?
|
| Reference Values | 1 | 1995 | 4925 | 0.020 |
Why?
|
| Platelet Count | 2 | 2001 | 777 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 1989 | 602 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1983 | 3763 | 0.020 |
Why?
|
| Bacteremia | 1 | 1994 | 980 | 0.020 |
Why?
|
| Quality Control | 1 | 1990 | 828 | 0.020 |
Why?
|
| Galactosyltransferases | 1 | 1989 | 276 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2008 | 358 | 0.020 |
Why?
|
| Blast Crisis | 1 | 1987 | 101 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2015 | 2773 | 0.020 |
Why?
|
| Hindlimb Suspension | 1 | 2007 | 75 | 0.020 |
Why?
|
| Plasmacytoma | 1 | 1987 | 171 | 0.020 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1988 | 207 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 877 | 0.020 |
Why?
|
| Osteonecrosis | 1 | 1988 | 229 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2007 | 186 | 0.020 |
Why?
|
| Ascorbic Acid | 1 | 1990 | 655 | 0.020 |
Why?
|
| Genes, Bacterial | 2 | 1991 | 1071 | 0.020 |
Why?
|
| Response Elements | 1 | 2008 | 308 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 2009 | 559 | 0.020 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1986 | 16 | 0.020 |
Why?
|
| Sheep | 1 | 1989 | 1441 | 0.020 |
Why?
|
| Incidence | 2 | 2015 | 21392 | 0.020 |
Why?
|
| Vitellogenins | 2 | 1975 | 21 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 1990 | 3602 | 0.020 |
Why?
|
| Bone Marrow Diseases | 1 | 1988 | 232 | 0.020 |
Why?
|
| Anemia | 3 | 1991 | 1511 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2012 | 1736 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 1992 | 1755 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2015 | 14495 | 0.020 |
Why?
|
| Mediastinal Neoplasms | 1 | 1989 | 402 | 0.020 |
Why?
|
| Leydig Cell Tumor | 1 | 1985 | 28 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 1986 | 201 | 0.020 |
Why?
|
| Fluorometry | 1 | 1985 | 100 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 1992 | 8515 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 14660 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 1988 | 401 | 0.020 |
Why?
|
| Laparotomy | 2 | 1986 | 465 | 0.020 |
Why?
|
| Nurses | 1 | 2015 | 2467 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 1985 | 337 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1990 | 998 | 0.020 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 1987 | 179 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1988 | 15697 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1993 | 4899 | 0.020 |
Why?
|
| Methotrexate | 1 | 1992 | 1719 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 1994 | 2753 | 0.020 |
Why?
|
| Codon | 4 | 1991 | 602 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1988 | 1351 | 0.020 |
Why?
|
| Microinjections | 1 | 1985 | 321 | 0.020 |
Why?
|
| Cryopreservation | 1 | 1990 | 717 | 0.020 |
Why?
|
| China | 1 | 1991 | 2339 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 658 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2007 | 605 | 0.010 |
Why?
|
| HeLa Cells | 2 | 1992 | 3105 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1987 | 899 | 0.010 |
Why?
|
| Hybridomas | 1 | 1985 | 442 | 0.010 |
Why?
|
| Zinc | 1 | 1989 | 689 | 0.010 |
Why?
|
| X Chromosome | 1 | 1988 | 815 | 0.010 |
Why?
|
| Thoracic Neoplasms | 1 | 1986 | 266 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1989 | 1529 | 0.010 |
Why?
|
| Bloodletting | 1 | 1983 | 23 | 0.010 |
Why?
|
| Reducing Agents | 1 | 1983 | 12 | 0.010 |
Why?
|
| Melphalan | 1 | 1985 | 420 | 0.010 |
Why?
|
| Fibrinopeptide A | 1 | 1983 | 43 | 0.010 |
Why?
|
| Mercaptoethanol | 1 | 1983 | 63 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2008 | 1955 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2003 | 69 | 0.010 |
Why?
|
| Lung Neoplasms | 2 | 1985 | 13262 | 0.010 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2008 | 620 | 0.010 |
Why?
|
| Hepatitis B Antibodies | 1 | 1984 | 157 | 0.010 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2003 | 102 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2009 | 1039 | 0.010 |
Why?
|
| Bacteria | 1 | 1994 | 2199 | 0.010 |
Why?
|
| Bacteriophage lambda | 1 | 1983 | 142 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2005 | 461 | 0.010 |
Why?
|
| Erythrocyte Indices | 1 | 1984 | 145 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1989 | 1388 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1989 | 1484 | 0.010 |
Why?
|
| Collagenases | 1 | 2003 | 221 | 0.010 |
Why?
|
| Folate Receptors, GPI-Anchored | 1 | 1982 | 23 | 0.010 |
Why?
|
| Radioligand Assay | 2 | 1995 | 366 | 0.010 |
Why?
|
| Sural Nerve | 1 | 1983 | 105 | 0.010 |
Why?
|
| Liver | 5 | 1983 | 7509 | 0.010 |
Why?
|
| Crossing Over, Genetic | 2 | 1975 | 95 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1985 | 1060 | 0.010 |
Why?
|
| Genetic Code | 2 | 1980 | 138 | 0.010 |
Why?
|
| Adiposity | 1 | 2012 | 1858 | 0.010 |
Why?
|
| Lithium Carbonate | 1 | 1983 | 179 | 0.010 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2002 | 73 | 0.010 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2002 | 71 | 0.010 |
Why?
|
| Drug Stability | 1 | 1983 | 290 | 0.010 |
Why?
|
| Interphase | 1 | 1983 | 228 | 0.010 |
Why?
|
| Tetrahydrofolates | 1 | 1982 | 58 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1982 | 311 | 0.010 |
Why?
|
| Potassium Cyanide | 1 | 1982 | 17 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1975 | 2299 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 1988 | 732 | 0.010 |
Why?
|
| Child | 8 | 1989 | 79806 | 0.010 |
Why?
|
| RNA | 2 | 1992 | 2722 | 0.010 |
Why?
|
| Immunodiffusion | 2 | 1979 | 150 | 0.010 |
Why?
|
| Cold Temperature | 2 | 1996 | 780 | 0.010 |
Why?
|
| Veins | 1 | 1986 | 765 | 0.010 |
Why?
|
| Neural Conduction | 1 | 1983 | 441 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Type II | 1 | 2001 | 10 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1985 | 965 | 0.010 |
Why?
|
| Placental Hormones | 1 | 1980 | 13 | 0.010 |
Why?
|
| Hemoglobins | 3 | 1985 | 1521 | 0.010 |
Why?
|
| Pregnancy Trimester, First | 1 | 1985 | 908 | 0.010 |
Why?
|
| Urea | 1 | 1983 | 446 | 0.010 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2001 | 86 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 10827 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1979 | 176 | 0.010 |
Why?
|
| Lipoproteins | 2 | 1975 | 882 | 0.010 |
Why?
|
| Phosphoserine | 1 | 2001 | 203 | 0.010 |
Why?
|
| Oocytes | 1 | 1985 | 1165 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2001 | 365 | 0.010 |
Why?
|
| Syndrome | 1 | 1987 | 3280 | 0.010 |
Why?
|
| Alkaline Phosphatase | 2 | 1998 | 865 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 2094 | 0.010 |
Why?
|
| Electrophoresis, Starch Gel | 2 | 1977 | 20 | 0.010 |
Why?
|
| Lithium | 1 | 1983 | 596 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1993 | 8555 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 1984 | 624 | 0.010 |
Why?
|
| Monocytes | 3 | 1986 | 2575 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 1980 | 11891 | 0.010 |
Why?
|
| Protein Subunits | 1 | 1983 | 943 | 0.010 |
Why?
|
| Cell-Free System | 2 | 1977 | 341 | 0.010 |
Why?
|
| Pituitary Hormones | 1 | 1980 | 182 | 0.010 |
Why?
|
| Ischemia | 1 | 1988 | 1893 | 0.010 |
Why?
|
| Insulin | 2 | 1985 | 6597 | 0.010 |
Why?
|
| Plasmapheresis | 1 | 1980 | 206 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 1988 | 8056 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1981 | 404 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1983 | 708 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 1996 | 58995 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1975 | 4319 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4357 | 0.010 |
Why?
|
| Dwarfism | 1 | 2000 | 137 | 0.010 |
Why?
|
| Pancreas | 2 | 1983 | 1677 | 0.010 |
Why?
|
| Electrochemistry | 1 | 1979 | 143 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 1983 | 652 | 0.010 |
Why?
|
| Immunoglobulins | 2 | 1987 | 859 | 0.010 |
Why?
|
| Software | 1 | 1993 | 4419 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1979 | 384 | 0.010 |
Why?
|
| Thrombomodulin | 1 | 1999 | 105 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1989 | 5496 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 1983 | 748 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1999 | 436 | 0.010 |
Why?
|
| Eosinophilia | 1 | 1983 | 559 | 0.010 |
Why?
|
| Hybrid Cells | 2 | 1992 | 422 | 0.010 |
Why?
|
| Aminopeptidases | 1 | 1978 | 95 | 0.010 |
Why?
|
| Acid Phosphatase | 1 | 1998 | 139 | 0.010 |
Why?
|
| Calcification, Physiologic | 1 | 1998 | 170 | 0.010 |
Why?
|
| Daunorubicin | 2 | 1990 | 156 | 0.010 |
Why?
|
| Bucladesine | 1 | 1977 | 118 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1981 | 832 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 1984 | 920 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1985 | 1784 | 0.010 |
Why?
|
| Bombyx | 1 | 1978 | 58 | 0.010 |
Why?
|
| Lung Diseases, Fungal | 1 | 1978 | 126 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2008 | 5649 | 0.010 |
Why?
|
| Cryptococcosis | 1 | 1978 | 104 | 0.010 |
Why?
|
| Environment | 1 | 2003 | 1118 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1998 | 257 | 0.010 |
Why?
|
| Myasthenia Gravis | 1 | 1980 | 213 | 0.010 |
Why?
|
| Sex Factors | 2 | 1985 | 10547 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1991 | 1544 | 0.010 |
Why?
|
| Integrin beta3 | 1 | 1997 | 121 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 1996 | 119 | 0.010 |
Why?
|
| LLC-PK1 Cells | 1 | 1996 | 125 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1977 | 429 | 0.010 |
Why?
|
| Chickens | 3 | 1991 | 860 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1996 | 136 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 1996 | 91 | 0.010 |
Why?
|
| Reoperation | 1 | 1986 | 4291 | 0.010 |
Why?
|
| Trypsin Inhibitors | 1 | 1975 | 36 | 0.010 |
Why?
|
| Hysterectomy | 1 | 1982 | 904 | 0.010 |
Why?
|
| Egg Proteins | 1 | 1975 | 57 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1978 | 573 | 0.010 |
Why?
|
| Growth | 1 | 1978 | 365 | 0.010 |
Why?
|
| Powders | 1 | 1975 | 79 | 0.010 |
Why?
|
| Hemodialysis, Home | 1 | 1975 | 18 | 0.010 |
Why?
|
| Agglutinins | 1 | 1975 | 28 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1988 | 8552 | 0.010 |
Why?
|
| Adenylate Cyclase Toxin | 1 | 1995 | 25 | 0.010 |
Why?
|
| Aprotinin | 1 | 1975 | 94 | 0.010 |
Why?
|
| Lung | 2 | 1985 | 9994 | 0.010 |
Why?
|
| Oxymetholone | 1 | 1975 | 9 | 0.010 |
Why?
|
| Enterobacter | 1 | 1975 | 46 | 0.010 |
Why?
|
| Chymotrypsin | 1 | 1975 | 138 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1978 | 623 | 0.010 |
Why?
|
| Microchemistry | 1 | 1975 | 55 | 0.010 |
Why?
|
| Music | 1 | 1978 | 245 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1995 | 154 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 1977 | 283 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1995 | 176 | 0.010 |
Why?
|
| Transgenes | 1 | 1998 | 1006 | 0.010 |
Why?
|
| Filtration | 1 | 1996 | 229 | 0.010 |
Why?
|
| Risk Factors | 2 | 2015 | 74359 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2005 | 3442 | 0.010 |
Why?
|
| Sterilization | 1 | 1996 | 130 | 0.010 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1977 | 367 | 0.010 |
Why?
|
| Axons | 1 | 1983 | 1673 | 0.010 |
Why?
|
| Cortisone | 1 | 1975 | 87 | 0.010 |
Why?
|
| Swine | 2 | 1996 | 5899 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1974 | 299 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1996 | 313 | 0.010 |
Why?
|
| Peroxidases | 1 | 1974 | 135 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1982 | 1266 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1974 | 251 | 0.010 |
Why?
|
| Cryptorchidism | 1 | 1975 | 151 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1998 | 1342 | 0.010 |
Why?
|
| Skin | 1 | 1988 | 4466 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1995 | 20509 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1994 | 304 | 0.010 |
Why?
|
| Radiography | 1 | 1985 | 6965 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1975 | 524 | 0.010 |
Why?
|
| Glutamates | 1 | 1974 | 391 | 0.010 |
Why?
|
| Contraceptives, Oral | 1 | 1975 | 554 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 2919 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1992 | 73 | 0.010 |
Why?
|
| Cyclin D3 | 1 | 1992 | 54 | 0.010 |
Why?
|
| Valine | 1 | 1974 | 409 | 0.010 |
Why?
|
| Hypopituitarism | 1 | 1975 | 248 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 1204 | 0.010 |
Why?
|
| Lectins | 1 | 1974 | 484 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1993 | 202 | 0.010 |
Why?
|
| Adenosine | 1 | 1977 | 834 | 0.010 |
Why?
|
| Age Factors | 4 | 2001 | 18416 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1980 | 4035 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1989 | 10344 | 0.010 |
Why?
|
| Hyperbilirubinemia | 1 | 1972 | 74 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1974 | 881 | 0.010 |
Why?
|
| Algorithms | 1 | 1993 | 13981 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 1992 | 248 | 0.010 |
Why?
|
| Leukocytosis | 1 | 1973 | 251 | 0.010 |
Why?
|
| Infant | 3 | 1991 | 36060 | 0.010 |
Why?
|
| Adenine | 1 | 1977 | 975 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 1994 | 80372 | 0.010 |
Why?
|
| Albumins | 1 | 1974 | 575 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1992 | 291 | 0.010 |
Why?
|
| RNA Splicing | 1 | 1996 | 915 | 0.010 |
Why?
|
| Drug Therapy | 2 | 1965 | 504 | 0.010 |
Why?
|
| Glutamine | 1 | 1974 | 576 | 0.010 |
Why?
|
| Cohort Studies | 1 | 1994 | 41335 | 0.010 |
Why?
|
| Bivalvia | 1 | 1991 | 53 | 0.010 |
Why?
|
| Arginine | 1 | 1975 | 934 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1992 | 398 | 0.010 |
Why?
|
| Serine | 1 | 1975 | 830 | 0.010 |
Why?
|
| Skin Physiological Phenomena | 1 | 1992 | 188 | 0.010 |
Why?
|
| Thyroxine | 1 | 1975 | 667 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1977 | 1993 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1992 | 825 | 0.010 |
Why?
|
| Safety | 1 | 1996 | 1148 | 0.010 |
Why?
|
| Extremities | 1 | 1996 | 867 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1994 | 1229 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1975 | 1400 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1972 | 437 | 0.010 |
Why?
|
| Somatostatin | 1 | 1992 | 447 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 1984 | 2942 | 0.010 |
Why?
|
| Growth Substances | 1 | 1992 | 768 | 0.010 |
Why?
|
| Parathyroidectomy | 1 | 1992 | 241 | 0.010 |
Why?
|
| Factor Xa | 1 | 1991 | 168 | 0.010 |
Why?
|
| Occupational Diseases | 1 | 1978 | 1486 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1985 | 4024 | 0.010 |
Why?
|
| Trifluoperazine | 1 | 1969 | 37 | 0.010 |
Why?
|
| Thioridazine | 1 | 1969 | 33 | 0.010 |
Why?
|
| Perphenazine | 1 | 1969 | 33 | 0.010 |
Why?
|
| Hypotension | 1 | 1996 | 883 | 0.010 |
Why?
|
| Cysteine | 1 | 1994 | 895 | 0.010 |
Why?
|
| Chlorpromazine | 1 | 1969 | 111 | 0.010 |
Why?
|
| Ethanol | 1 | 1996 | 1323 | 0.010 |
Why?
|
| Prospective Studies | 4 | 1999 | 54303 | 0.010 |
Why?
|
| Species Specificity | 1 | 1993 | 2418 | 0.010 |
Why?
|
| Gene Library | 1 | 1992 | 1060 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 8651 | 0.010 |
Why?
|
| Multigene Family | 1 | 1992 | 1077 | 0.000 |
Why?
|
| Oligonucleotides | 1 | 1991 | 588 | 0.000 |
Why?
|
| Estradiol | 1 | 1975 | 1932 | 0.000 |
Why?
|
| RNA, Neoplasm | 1 | 1991 | 749 | 0.000 |
Why?
|
| Nucleotide Mapping | 1 | 1987 | 19 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1983 | 6551 | 0.000 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1988 | 210 | 0.000 |
Why?
|
| Chromatography | 1 | 1987 | 189 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1988 | 1316 | 0.000 |
Why?
|
| Extracellular Matrix | 1 | 1994 | 1726 | 0.000 |
Why?
|
| Peptide Mapping | 1 | 1987 | 262 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1997 | 5870 | 0.000 |
Why?
|
| Thyroidectomy | 1 | 1992 | 902 | 0.000 |
Why?
|
| Haploidy | 1 | 1986 | 133 | 0.000 |
Why?
|
| Phenindione | 1 | 1964 | 1 | 0.000 |
Why?
|
| Chromium Isotopes | 1 | 1964 | 29 | 0.000 |
Why?
|
| Iron Isotopes | 1 | 1964 | 19 | 0.000 |
Why?
|
| Hemoglobinuria | 1 | 1964 | 13 | 0.000 |
Why?
|
| Hemosiderin | 1 | 1964 | 41 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1990 | 1368 | 0.000 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1991 | 1130 | 0.000 |
Why?
|
| Acetylcholinesterase | 1 | 1964 | 156 | 0.000 |
Why?
|
| Multicenter Studies as Topic | 1 | 1990 | 1722 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1975 | 4902 | 0.000 |
Why?
|
| Testosterone | 1 | 1975 | 2470 | 0.000 |
Why?
|
| Methylation | 1 | 1986 | 1082 | 0.000 |
Why?
|
| Hematologic Tests | 1 | 1964 | 238 | 0.000 |
Why?
|
| Vitamin E | 1 | 1968 | 872 | 0.000 |
Why?
|
| Stomatitis | 1 | 1986 | 271 | 0.000 |
Why?
|
| Nausea | 1 | 1986 | 678 | 0.000 |
Why?
|
| Dextrans | 1 | 1964 | 574 | 0.000 |
Why?
|
| Vomiting | 1 | 1986 | 650 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1992 | 4090 | 0.000 |
Why?
|
| Alopecia | 1 | 1986 | 414 | 0.000 |
Why?
|
| Mass Screening | 1 | 1997 | 5423 | 0.000 |
Why?
|
| Calmodulin | 1 | 1982 | 217 | 0.000 |
Why?
|
| Genetic Techniques | 1 | 1983 | 428 | 0.000 |
Why?
|
| Receptors, Drug | 1 | 1980 | 157 | 0.000 |
Why?
|
| Birth Weight | 1 | 1968 | 2097 | 0.000 |
Why?
|
| Triticum | 1 | 1979 | 89 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1981 | 1433 | 0.000 |
Why?
|
| Gene Frequency | 1 | 1986 | 3615 | 0.000 |
Why?
|
| Lymphatic Metastasis | 1 | 1986 | 2943 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1987 | 2536 | 0.000 |
Why?
|
| Plants | 1 | 1979 | 317 | 0.000 |
Why?
|
| Acetylcholine | 1 | 1980 | 629 | 0.000 |
Why?
|
| Cerebrovascular Disorders | 1 | 1965 | 1501 | 0.000 |
Why?
|
| Chorion | 1 | 1978 | 114 | 0.000 |
Why?
|
| Air Microbiology | 1 | 1978 | 94 | 0.000 |
Why?
|
| Edetic Acid | 1 | 1978 | 282 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1990 | 10182 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1982 | 1173 | 0.000 |
Why?
|
| Egg Yolk | 1 | 1975 | 24 | 0.000 |
Why?
|
| Child, Preschool | 2 | 1989 | 42063 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1975 | 306 | 0.000 |
Why?
|
| Equipment and Supplies | 1 | 1978 | 275 | 0.000 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 1964 | 1067 | 0.000 |
Why?
|
| Methylene Blue | 1 | 1974 | 157 | 0.000 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 1972 | 46 | 0.000 |
Why?
|
| Inclusion Bodies | 1 | 1973 | 281 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1969 | 6796 | 0.000 |
Why?
|
| Biomedical Research | 1 | 1965 | 3426 | 0.000 |
Why?
|
| Vitamin E Deficiency | 1 | 1968 | 30 | 0.000 |
Why?
|
| Shock | 1 | 1970 | 317 | 0.000 |
Why?
|
| Transplantation, Homologous | 1 | 1975 | 4810 | 0.000 |
Why?
|
| Renal Dialysis | 1 | 1975 | 1801 | 0.000 |
Why?
|
| Epoetin Alfa | 1 | 1964 | 79 | 0.000 |
Why?
|
| Hospitalization | 1 | 1975 | 10790 | 0.000 |
Why?
|